---
document_datetime: 2025-11-23 08:02:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/rasilamlo.html
document_name: rasilamlo.html
version: success
processing_time: 0.1327206
conversion_datetime: 2025-12-28 10:17:20.577905
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Rasilamlo

[RSS](/en/individual-human-medicine.xml/65737)

##### Withdrawn

This medicine's authorisation has been withdrawn

aliskiren hemifumarate / amlodipine besilate

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Rasilamlo](#news-on)
- [More information on Rasilamlo](#more-information-on-rasilamlo-1074)
- [More information on Rasilamlo](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 25 June 2015, the European Commission withdrew the marketing authorisation for Rasilamlo (aliskiren / amlodipine) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Novartis Europharm Ltd, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Rasilamlo was granted marketing authorisation in the EU on 14 April 2011 for treatment of essential hypertension in adult patients whose blood pressure is not adequately controlled with aliskiren or amlodipine used alone. The product had not been marketed in the EU since 2014. The European Public Assessment Report (EPAR) for Rasilamlo is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Rasilamlo : EPAR - Summary for the public

English (EN) (547.33 KB - PDF)

**First published:** 06/06/2011

**Last updated:** 28/03/2017

[View](/en/documents/overview/rasilamlo-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-506)

български (BG) (625.8 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/bg/documents/overview/rasilamlo-epar-summary-public_bg.pdf)

español (ES) (546.18 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/es/documents/overview/rasilamlo-epar-summary-public_es.pdf)

čeština (CS) (607.91 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/cs/documents/overview/rasilamlo-epar-summary-public_cs.pdf)

dansk (DA) (539.34 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/da/documents/overview/rasilamlo-epar-summary-public_da.pdf)

Deutsch (DE) (542.97 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/de/documents/overview/rasilamlo-epar-summary-public_de.pdf)

eesti keel (ET) (543.39 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/et/documents/overview/rasilamlo-epar-summary-public_et.pdf)

ελληνικά (EL) (631.27 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/el/documents/overview/rasilamlo-epar-summary-public_el.pdf)

français (FR) (543.76 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/fr/documents/overview/rasilamlo-epar-summary-public_fr.pdf)

hrvatski (HR) (560.79 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/hr/documents/overview/rasilamlo-epar-summary-public_hr.pdf)

italiano (IT) (543.57 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/it/documents/overview/rasilamlo-epar-summary-public_it.pdf)

latviešu valoda (LV) (580.24 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/lv/documents/overview/rasilamlo-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (566.7 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/lt/documents/overview/rasilamlo-epar-summary-public_lt.pdf)

magyar (HU) (601.46 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/hu/documents/overview/rasilamlo-epar-summary-public_hu.pdf)

Malti (MT) (608.3 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/mt/documents/overview/rasilamlo-epar-summary-public_mt.pdf)

Nederlands (NL) (544.14 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/nl/documents/overview/rasilamlo-epar-summary-public_nl.pdf)

polski (PL) (607.28 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/pl/documents/overview/rasilamlo-epar-summary-public_pl.pdf)

português (PT) (544.93 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/pt/documents/overview/rasilamlo-epar-summary-public_pt.pdf)

română (RO) (565.23 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/ro/documents/overview/rasilamlo-epar-summary-public_ro.pdf)

slovenčina (SK) (603.83 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/sk/documents/overview/rasilamlo-epar-summary-public_sk.pdf)

slovenščina (SL) (598.36 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/sl/documents/overview/rasilamlo-epar-summary-public_sl.pdf)

Suomi (FI) (539.89 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/fi/documents/overview/rasilamlo-epar-summary-public_fi.pdf)

svenska (SV) (541.6 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

28/03/2017

[View](/sv/documents/overview/rasilamlo-epar-summary-public_sv.pdf)

## Product information

Rasilamlo : EPAR - Product Information

English (EN) (1.71 MB - PDF)

**First published:** 06/06/2011

**Last updated:** 21/03/2017

[View](/en/documents/product-information/rasilamlo-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-656)

български (BG) (2.22 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/bg/documents/product-information/rasilamlo-epar-product-information_bg.pdf)

español (ES) (1.71 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/es/documents/product-information/rasilamlo-epar-product-information_es.pdf)

čeština (CS) (1.97 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/cs/documents/product-information/rasilamlo-epar-product-information_cs.pdf)

dansk (DA) (1.49 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/da/documents/product-information/rasilamlo-epar-product-information_da.pdf)

Deutsch (DE) (1.53 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/de/documents/product-information/rasilamlo-epar-product-information_de.pdf)

eesti keel (ET) (1.6 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/et/documents/product-information/rasilamlo-epar-product-information_et.pdf)

ελληνικά (EL) (2.23 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/el/documents/product-information/rasilamlo-epar-product-information_el.pdf)

français (FR) (1.8 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/fr/documents/product-information/rasilamlo-epar-product-information_fr.pdf)

hrvatski (HR) (1.79 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/hr/documents/product-information/rasilamlo-epar-product-information_hr.pdf)

íslenska (IS) (1.56 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/is/documents/product-information/rasilamlo-epar-product-information_is.pdf)

italiano (IT) (1.69 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/it/documents/product-information/rasilamlo-epar-product-information_it.pdf)

latviešu valoda (LV) (1.89 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/lv/documents/product-information/rasilamlo-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.83 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/lt/documents/product-information/rasilamlo-epar-product-information_lt.pdf)

magyar (HU) (2.04 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/hu/documents/product-information/rasilamlo-epar-product-information_hu.pdf)

Malti (MT) (2.2 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/mt/documents/product-information/rasilamlo-epar-product-information_mt.pdf)

Nederlands (NL) (1.52 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/nl/documents/product-information/rasilamlo-epar-product-information_nl.pdf)

norsk (NO) (1.58 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/no/documents/product-information/rasilamlo-epar-product-information_no.pdf)

polski (PL) (2.23 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/pl/documents/product-information/rasilamlo-epar-product-information_pl.pdf)

português (PT) (1.64 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/pt/documents/product-information/rasilamlo-epar-product-information_pt.pdf)

română (RO) (1.8 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/ro/documents/product-information/rasilamlo-epar-product-information_ro.pdf)

slovenčina (SK) (2.04 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/sk/documents/product-information/rasilamlo-epar-product-information_sk.pdf)

slovenščina (SL) (2.09 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/sl/documents/product-information/rasilamlo-epar-product-information_sl.pdf)

Suomi (FI) (1.59 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/fi/documents/product-information/rasilamlo-epar-product-information_fi.pdf)

svenska (SV) (1.51 MB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/sv/documents/product-information/rasilamlo-epar-product-information_sv.pdf)

25/06/2015

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Rasilamlo : EPAR - All Authorised presentations

English (EN) (522.88 KB - PDF)

**First published:** 06/06/2011

**Last updated:** 21/03/2017

[View](/en/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_en.pdf)

[Other languages (23)](#file-language-dropdown-973)

български (BG) (584.44 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/bg/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_bg.pdf)

español (ES) (527.6 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/es/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_es.pdf)

čeština (CS) (565.61 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/cs/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (524.84 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/da/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (525.6 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/de/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (528.71 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/et/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (583.39 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/el/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_el.pdf)

français (FR) (527.52 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/fr/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_fr.pdf)

íslenska (IS) (523.15 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/is/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_is.pdf)

italiano (IT) (526.02 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/it/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (575.03 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/lv/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (555.41 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/lt/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (570.27 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/hu/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (567.84 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/mt/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (525.68 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/nl/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (524.48 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/no/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_no.pdf)

polski (PL) (553.74 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/pl/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_pl.pdf)

português (PT) (526.54 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/pt/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_pt.pdf)

română (RO) (554.03 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/ro/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (569.32 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/sk/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (540.77 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/sl/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (526.26 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/fi/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (524.35 KB - PDF)

**First published:**

06/06/2011

**Last updated:**

21/03/2017

[View](/sv/documents/all-authorised-presentations/rasilamlo-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Rasilamlo Active substance

- aliskiren
- amlodipine

International non-proprietary name (INN) or common name

- aliskiren hemifumarate
- amlodipine besilate

Therapeutic area (MeSH) Hypertension Anatomical therapeutic chemical (ATC) code C09XA53

### Pharmacotherapeutic group

Agents acting on the renin-angiotensin system

### Therapeutic indication

Rasilamlo is indicated for the treatment of essential hypertension in adult patients whose blood pressure is not adequately controlled with aliskiren or amlodipine used alone.

## Authorisation details

EMA product number EMEA/H/C/002073 Marketing authorisation holder

Novartis Europharm Ltd

Wimblehurst Road

Marketing authorisation issued 14/04/2011 Withdrawal of marketing authorisation 25/06/2015 Revision 7

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Rasilamlo : EPAR - Procedural steps taken and scientific information after authorisation

Reference Number: EMA/992265/2011

English (EN) (957.74 KB - PDF)

**First published:** 16/03/2012

**Last updated:** 28/03/2017

[View](/en/documents/procedural-steps-after/rasilamlo-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Rasilamlo-H-C-PSUSA-00000089-201409 : EPAR - Scientific conclusions and grounds recommending the variation

Reference Number: EMA/CHMP/333074/2015

English (EN) (554.55 KB - PDF)

**First published:** 14/07/2015

**Last updated:** 21/03/2017

[View](/en/documents/scientific-conclusion/rasilamlo-h-c-psusa-00000089-201409-epar-scientific-conclusions-and-grounds-recommending-variation_en.pdf)

Rasilamlo-H-C-2073-A31-84 : EPAR - Assessment Report - Article 31

Adopted

Reference Number: EMA/PRAC/294920/2014

English (EN) (976.52 KB - PDF)

**First published:** 25/09/2014

**Last updated:** 28/03/2017

[View](/en/documents/variation-report/rasilamlo-h-c-2073-a31-84-epar-assessment-report-article-31_en.pdf)

Rasilamlo-H-C-2073-A31-84  : EPAR - Scientific conclusions, grounds for variation to the terms of the marketing authorisations and detailed explanation of the scientific grounds for the differences from the PRAC recommen...

English (EN) (527.75 KB - PDF)

**First published:** 25/09/2014

**Last updated:** 28/03/2017

[View](/en/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_en.pdf)

[Other languages (22)](#file-language-dropdown-170)

български (BG) (87.49 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/bg/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_bg.pdf)

español (ES) (50.51 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/es/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_es.pdf)

čeština (CS) (82.81 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/cs/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_cs.pdf)

dansk (DA) (49.01 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/da/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_da.pdf)

Deutsch (DE) (53.54 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/de/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_de.pdf)

eesti keel (ET) (50.6 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/et/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_et.pdf)

ελληνικά (EL) (89.54 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/el/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_el.pdf)

français (FR) (51.91 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/fr/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_fr.pdf)

hrvatski (HR) (80.12 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/hr/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_hr.pdf)

italiano (IT) (51.13 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/it/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_it.pdf)

latviešu valoda (LV) (81.63 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/lv/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_lv.pdf)

lietuvių kalba (LT) (82.54 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/lt/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_lt.pdf)

magyar (HU) (68.7 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/hu/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_hu.pdf)

Malti (MT) (84.23 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/mt/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_mt.pdf)

Nederlands (NL) (49.82 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/nl/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_nl.pdf)

polski (PL) (83.62 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/pl/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_pl.pdf)

português (PT) (49.74 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/pt/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_pt.pdf)

română (RO) (88.19 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/ro/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_ro.pdf)

slovenčina (SK) (81.5 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/sk/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_sk.pdf)

slovenščina (SL) (79.79 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/sl/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_sl.pdf)

Suomi (FI) (49.15 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/fi/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_fi.pdf)

svenska (SV) (50.18 KB - PDF)

**First published:**

25/09/2014

**Last updated:**

28/03/2017

[View](/sv/documents/scientific-conclusion/rasilamlo-h-c-2073-a31-84-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommen_sv.pdf)

Rasilamlo-H-C-2073-PSUV-90 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Reference Number: EMA/554133/2014

English (EN) (530.15 KB - PDF)

**First published:** 15/09/2014

**Last updated:** 28/03/2017

[View](/en/documents/scientific-conclusion/rasilamlo-h-c-2073-psuv-90-epar-scientific-conclusions-and-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

Rasilamlo H-C-2073-A20-16 : EPAR - Assessment Report - Variation

Reference Number: EMA/390880/2012

English (EN) (907.71 KB - PDF)

**First published:** 20/09/2012

**Last updated:** 28/03/2017

[View](/en/documents/variation-report/rasilamlo-h-c-2073-a20-16-epar-assessment-report-variation_en.pdf)

Rasilamlo-H-C-2073-WS-169 : EPAR - Assessment Report - Variation

Reference Number: EMA/CHMP/479606/2012

English (EN) (673.48 KB - PDF)

**First published:** 20/09/2012

**Last updated:** 28/03/2017

[View](/en/documents/variation-report/rasilamlo-h-c-2073-ws-169-epar-assessment-report-variation_en.pdf)

## Initial marketing authorisation documents

Rasilamlo : EPAR - Public assessment report

Adopted

English (EN) (2.23 MB - PDF)

**First published:** 06/06/2011

**Last updated:** 28/03/2017

[View](/en/documents/assessment-report/rasilamlo-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Rasilamlo

Adopted

Reference Number: EMA/CHMP/124404/2011

English (EN) (576.09 KB - PDF)

**First published:** 17/02/2011

**Last updated:** 28/03/2017

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-rasilamlo_en.pdf)

#### News on Rasilamlo

[Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 May 2013](/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-13-16-may-2013) 17/05/2013

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 February 2012](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-13-16-february-2012) 17/02/2012

#### More information on Rasilamlo

Questions and answers on the review aliskiren-containing medicines

Reference Number: EMA/113677/2012

English (EN) (60.98 KB - PDF)

**First published:** 17/02/2012

**Last updated:** 17/02/2012

[View](/en/documents/medicine-qa/questions-and-answers-review-aliskiren-containing-medicines_en.pdf)

Questions and answers on ongoing review of aliskiren-containing medicines

Reference Number: EMA/990270/2011

English (EN) (65.3 KB - PDF)

**First published:** 22/12/2011

**Last updated:** 22/12/2011

[View](/en/documents/medicine-qa/questions-and-answers-ongoing-review-aliskiren-containing-medicines_en.pdf)

#### More information on Rasilamlo

- [Renin-angiotensin-system (RAS)-acting agents - referral](/en/medicines/human/referrals/renin-angiotensin-system-ras-acting-agents)
- [Angioedema among patients with hypertension treated with aliskiren or other anti-hypertensive medications in the US - a cohort Study and a nested case-control analysis using health claims data - post-authorisation study](https://catalogues.ema.europa.eu/study/17554)

**This page was last updated on** 28/03/2017

## Share this page

[Back to top](#main-content)